Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
A topical dental cream containing 20% pure silica, used as a control intervention in clinical research for the treatment of dentin hypersensitivity. The cream functions by mechanically occluding open dentin tubules, which prevents the hydrodynamic flow of fluid that stimulates pulpal nerve endings. It was notably employed as a comparator in a Phase 2 randomized, double-blind clinical trial (NCT02918617) conducted by the University of Texas Health Science Center at San Antonio to evaluate the efficacy of nanohydroxyapatite-containing toothpastes and creams. Subjects applied the cream using custom-fabricated trays for 5 minutes once daily to assess its ability to provide relief through physical tubule blockage.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on silica control cream.